Board of Directors

Frank L. Jaksch Jr.
CEO
Frank L. Jaksch Jr.
CEO


Frank L. Jaksch Jr., 48, is a co-founder of the Company and has served as a member of Board since February 2000. Mr. Jaksch served as Chairman of the Board from May 2010 to October 2011 and was its Co-Chairman from February 2000 to May 2010. Mr. Jaksch currently serves as our Chief Executive Officer.

Mr. Jaksch brought the Company public in June 2008, listed the Company on NASDAQ in April 2016. Under his leadership, ChromaDex has focused on developing a comprehensive na... 

Steve R. Allen
Chairman
Steve R. Allen
Chairman


Stephen Allen, 67, has served as Chairman of the Board since February 2015, and as a director of the Board, Chair of the Nominating and Corporate Governance Committee and member of the Compensation Committee since January 2014.

Until 2009, Mr. Allen worked for Nestlé, at which point he retired from a 30 year career where he served in various sales, marketing and management roles, including 7 years serving in Nestlé’s Mergers and Acquisitions department. Until 2012, Mr. A... 

Jeff Baxter
Non-Executive Director
Jeff Baxter
Non-Executive Director


Mr. Baxter, 55, has served as a director of the Company since April 2015 and has served as a member of the Audit Committee and the Nominating and Corporate Governance Committee since April 2015.

Mr. Baxter has served as President and CEO and a Director of VBI Vaccines, Inc. (NASDAQ:VBIV) since 2009. Previously, he was managing partner for the venture capital firm, The Column Group, where he played a pivotal role in the creation of several biotech companies including Immune... 

Steven A. Block
Non-Executive Director
Steven A. Block
Non-Executive Director


Stephen A. Block, 72, has been a director of the Company since October 2007 and Chair of the Compensation Committee and a member of the Audit Committee since October 2007. From May 2010 to October 2011, Mr. Block served as Lead Independent Director to the Board.

Mr. Block is also a director and chair of the nominating and corporate governance committee and a member of the audit committee of Senomyx, Inc. (NASDAQ:SNMX). He has served on the board of directors of Senomyx, Inc.... 

Rob Fried
President and Chief Strategy Officer
Rob Fried
President and Chief Strategy Officer


Robert Fried, 57, has served as a director of the Company since July 2015 and has served as a member of the Nominating and Corporate Governance Committee from July 2015 to March 2017. In March 2017, Mr. Fried was appointed as President and Chief Strategy Officer of the Company.

Mr. Fried served as Chairman of the Board of Directors of IDI, Inc. (formerly Tiger Media, Inc.), an information solutions provider focused on the data fusion market and formerly a Chinese adverti... 

Kurt Gustafson
Non-Executive Director
Kurt Gustafson
Non-Executive Director


Kurt A. Gustafson, 49, has been a director of the Company since October 2016 and Chair of the Audit Committee since October 2016.

Mr. Gustafson has more than 25 years of diverse experience in corporate finance. He currently serves as chief financial officer, principal accounting officer and executive vice president of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI). From 2009 to 2013, he served as the chief financial officer of Halozyme Therapeutics, Inc. (NASDAQ: HALO) From... 

Tony Lau
Non-Executive Director
Tony Lau
Non-Executive Director
Steven D. Rubin
Non-Executive Director
Steven D. Rubin
Non-Executive Director


Steven D. Rubin, 56, has been a director of the Company and a member of the Nominating and Corporate Governance Committee since March 2017.

Mr. Rubin has served as OPKO Health, Inc.’s (NASDAQ: OPK) Executive Vice President – Administration since May 2007 and as a director of since February 2007. Mr. Rubin is a member of The Frost Group, LLC, a private investment firm. He has extensive experience as a practicing lawyer, and as general counsel and board member to multiple publ... 

Wendy Yu
Non-Executive Director
Wendy Yu
Non-Executive Director